Industry expert estimate that brands have already collectively invested between Rs 1,800 crore to Rs 2,000 crore in ...

(Reuters) - Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre in Richmond, U.S., aiming to boost its pipeline for new ...

Haleon is investing $54.2 million to upgrade its existing plant at 1211 Sherwood Ave. The center is one of three that the UK-based company uses for research and development for its brands that include ...

Glenn Youngkin dubbing the region a “pharma corridor” during Monday’s announcement of major investments and opportunities at Haleon, an international drug manufacturing company. The United ...

RICHMOND, Va. — Haleon, a global company behind home healthcare products like Advil, Tums and Aquafresh, announced Monday its plan to upgrade its Richmond research and development facility.

Haleon, an international manufacturer of medicine, vitamins and toothpaste, will upgrade its lab in Richmond’s North Side at a cost of $54 million, the company announced Monday. Based in England ...

GSK's consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion).

In an interview with Gulf Business, Charles Leslie, global business lead for the Pain Portfolio & Systemics at Haleon, outlines key consumer health trends reshaping the healthcare sector ...